(Q35745390)

English

Cellular distribution and clinical value of urokinase-type plasminogen activator, its receptor, and plasminogen activator inhibitor-2 in esophageal squamous cell carcinoma

scientific article published on February 2000

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Cellular distribution and clinical value of urokinase-type plasminogen activator, its receptor, and plasminogen activator inhibitor-2 in esophageal squamous cell carcinoma (English)

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

esophageal squamous cell carcinoma

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

H Shiomi

1

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Y Eguchi

2

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

T Tani

3

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

M Kodama

4

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

T Hattori

5

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

language of work or name

0 references

publication date

1 February 2000

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

The American Journal of Pathology

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

156

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

567-575

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Invasion by esophageal cancer cells: functional contribution of the urokinase plasminogen activation system, and inhibition by antisense oligonucleotides to urokinase or urokinase receptor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850041

12 July 2018

Antisense inhibition of urokinase: effect on malignancy in a human osteosarcoma cell line

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850041

12 July 2018

The urokinase-type plasminogen activator system in cancer metastasis: a review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850041

12 July 2018

Biology and biochemistry of proteinases in tumor invasion.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850041

12 July 2018

Prognostic value of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitors PAI-1 and PAI-2 in breast carcinomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850041

12 July 2018

Binding of urokinase to its receptor promotes migration and invasion of human melanoma cells in vitro

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850041

12 July 2018

Urokinase receptor and colorectal cancer survival.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850041

12 July 2018

Increased urokinase receptor levels in human gastrointestinal neoplasia and related liver metastases.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850041

12 July 2018

A serine proteinase inhibitor locus at 18q21.3 contains a tandem duplication of the human squamous cell carcinoma antigen gene

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850041

12 July 2018

Plasminogen activator inhibitor type 2 inhibits tumor necrosis factor alpha-induced apoptosis. Evidence for an alternate biological function

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850041

12 July 2018

The human urokinase-plasminogen activator gene and its promoter.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850041

12 July 2018

Plasminogen activators, tissue degradation, and cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850041

12 July 2018

Plasminogen activation initiated by single-chain urokinase-type plasminogen activator. Potentiation by U937 monocytes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850041

12 July 2018

Non-radioactive labeling of RNA transcripts in vitro with the hapten digoxigenin (DIG); hybridization and ELISA-based detection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850041

12 July 2018

Plasminogen activators and cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850041

12 July 2018

Differential protease expression by cutaneous squamous and basal cell carcinomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850041

12 July 2018

Urokinase-type plasminogen activator is expressed in stromal cells and its receptor in cancer cells at invasive foci in human colon adenocarcinomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850041

12 July 2018

Non-radioactive detection of nerve growth factor receptor (NGFR) mRNA in rat brain using in situ hybridization histochemistry

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850041

12 July 2018

Endogenous receptor-bound urokinase mediates tissue invasion of the human lung carcinoma cell lines A549 and Calu-1

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850041

12 July 2018

Strong prognostic impact of tumor-associated urokinase-type plasminogen activator in completely resected adenocarcinoma of the esophagus.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850041

25 September 2018

Prognostic relevance of plasminogen activators and their inhibitors in colorectal cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850041

25 September 2018

Localization of urokinase-type plasminogen activator, plasminogen activator inhibitor-1, 2 and plasminogen in colon cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850041

25 September 2018

Immunohistochemical evaluation of squamous cell carcinoma antigen and S-100 protein-positive cells in human malignant esophageal tissues

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850041

25 September 2018

Urokinase-plasminogen activator, a marker for aggressive breast carcinomas. Preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2964761-X

7 January 2021

Tumour-associated proteolytic factors uPA and PAI-1 and survival in totally resected gastric cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2964761-X

7 January 2021

Urokinase plasminogen activator and urokinase plasminogen activator receptor in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2964761-X

7 January 2021

Plasminogen activators in oesophageal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2964761-X

7 January 2021

Immunohistochemical detection of the receptor for urokinase plasminogen activator in human colon cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2964761-X

7 January 2021

Cellular localization of urokinase-type plasminogen activator, its inhibitors, and their mRNAs in breast cancer tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2964761-X

7 January 2021

Mitogenic Effects of Urokinase on Melanoma Cells Are Independent of High Affinity Binding to the Urokinase Receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2964761-X

7 January 2021

The receptor for urokinase-type plasminogen activator is not essential for mouse development or fertility

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2964761-X

7 January 2021

CYFRA 21-1 is a useful marker for esophageal squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2964761-X

7 January 2021

Biological role of SCC antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2964761-X

7 January 2021

Plasminogen Activator Inhibitor Type 2 Inhibits Tumor Necrosis Factor α-induced Apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2964761-X

7 January 2021

Prognostic impact of urokinase, urokinase receptor, and type 1 plasminogen activator inhibitor in squamous and large cell lung cancer tissue

1 reference

https://pubmed.ncbi.nlm.nih.gov/10666386

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical impact of the plasminogen activation system in tumor invasion and metastasis: prognostic relevance and target for therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/10666386

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Proteases as prognostic markers in cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/10666386

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic significance of urokinase-type plasminogen activator expression in squamous cell carcinomas of the esophagus

1 reference

https://pubmed.ncbi.nlm.nih.gov/10666386

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Three decades of treatment of esophageal squamous carcinoma at the Massachusetts General Hospital

1 reference

https://pubmed.ncbi.nlm.nih.gov/10666386

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Receptor for urokinase is present in tumor-associated macrophages in ductal breast carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/10666386

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/S0002-9440(10)64761-X

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

release_tmejllavebhdlo7vl4a6hminpy

1 reference

https://api.fatcat.wiki/v0/release/tmejllavebhdlo7vl4a6hminpy

24 November 2022

based on heuristic

mapped directly with Wikidata item

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35745390&oldid=1844530010"